Fresenius Medcare: stock down after Q1 results
(CercleFinance.com) - Fresenius Medical Care shares are down nearly 4% in Frankfurt today, after the dialysis specialist reported weak Q1 results, with non-recurrent EPS down 20% to 0.
68 euro (-23% at constant exchange rates).
Adjusted operating profit fell 15% to 403 million euros (-19% at constant exchange rates), due to cost inflation and the unfavourable effects of Covid-19, on sales that rose by 8% to 4.55 billion euros (+2% in organic terms).
Based on these results, which are in line with its expectations, Fresenius MedCare confirms its targets for 2022, expecting low to mid-single-digit growth in both sales and earnings.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
68 euro (-23% at constant exchange rates).
Adjusted operating profit fell 15% to 403 million euros (-19% at constant exchange rates), due to cost inflation and the unfavourable effects of Covid-19, on sales that rose by 8% to 4.55 billion euros (+2% in organic terms).
Based on these results, which are in line with its expectations, Fresenius MedCare confirms its targets for 2022, expecting low to mid-single-digit growth in both sales and earnings.
Copyright (c) 2022 CercleFinance.com. All rights reserved.